Diageo plc:企業の戦略・SWOT・財務情報

◆英語タイトル:Diageo plc - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C3807
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:消費財
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Diageo plc – Strategy, SWOT and Corporate Finance Report
Summary

Diageo plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Diageo plc (Diageo or ‘the company’) produces and distributes a large collection of branded premium spirits, beer and wine. The company’s product offering includes Scotch whisky, gin, vodka, rum, ready to drink beverages, beer, liqueur, tequila, Canadian whisky, American whiskey, progressive adult beverages, brandy, and wine. It markets these products under various brands such as Johnnie Walker, Smirnoff, Baileys, Captain Morgan, Tanqueray, Guinness, McDowell’s No.1 and CIROC and distributes them through various independent wholesalers and retailers, spirits and wine distributors and brokers, beer distributors, subsidiary companies, joint venture arrangements and third party distributors. Diageo is headquartered in London, the UK.

Scope

- Detailed information on Diageo plc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Diageo plc in the form of a SWOT analysis
- An in-depth view of the business model of Diageo plc including a breakdown and examination of key business segments
- Intelligence on Diageo plc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Diageo plc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Diageo plc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Diageo plc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Diageo plc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Diageo plc: Company Overview 9
Diageo plc: Overview and Key Facts 9
Diageo plc: Overview 9
Diageo plc: Key Facts 9
Diageo plc: Key Employees 10
Diageo plc: Key Employee Biographies 12
Diageo plc: Major Products and Services 18
Diageo plc: Company History 20
Diageo plc: Management Statement 26
Diageo plc: Locations and Subsidiaries 30
Diageo plc: Key Competitors 31
Diageo plc: Company Analysis 32
Diageo plc: Business Description 32
Diageo plc: SWOT Analysis 35
Diageo plc: SWOT Overview 35
Diageo plc: Strengths 35
Diageo plc: Weaknesses 37
Diageo plc: Opportunities 37
Diageo plc: Threats 38
Diageo plc: Corporate Financial Deals Activity 40
Diageo plc: Financial Deals Overview 40
Diageo plc: Targets and Partners 42
Diageo plc: Top Deals 2014 – 2018YTD* 43
Diageo plc: Advisors 44
Diageo plc: Top Legal Advisors 44
Diageo plc: Top Financial Advisors 44
Diageo plc: Mergers and Acquisitions 45
Diageo plc: Capital Raising 46
Diageo plc: Partnership 47
Diageo plc: Divestments 48
Diageo plc: Recent Developments 49
Diageo plc: News and Events Summary 49
Diageo plc: Business Expansion 51
Diageo plc: Financial Performance 54
Diageo plc: Strategy and Operations 54
Appendix 55
Contact Us 55
Methodology 55
About MarketLine 56

List of Tables
Table 1: Diageo plc: Key Facts
Table 2: Diageo plc: Key Employees
Table 3: Diageo plc: Locations and Subsidiaries
Table 4: Diageo plc: Key Competitors
Table 5: Diageo plc: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Diageo plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Diageo plc: M&A Average Deal Size - Value (US$m)
Table 8: Diageo plc: Targets and Partners
Table 9: Diageo plc: Top Deals 2014 - 2018YTD*
Table 10: Diageo plc: Legal Advisor Ranking by Value (US$m)
Table 11: Diageo plc: Financial Advisor Ranking by Value (US$m)
Table 12: Diageo plc: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Diageo plc: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Diageo plc: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 15: Diageo plc: Capital Raising by Deal Type (2014 - YTD*2018)
Table 16: Diageo plc: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 17: Diageo plc: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 18: Diageo plc: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 19: Diageo plc: Divestments by Geography (2014 - YTD*2018)
Table 20: Diageo plc: News and Events Summary
Table 21: Diageo plc: Business Expansion
Table 22: Diageo plc: Financial Performance
Table 23: Diageo plc: Strategy and Operations

List of Figures
Figure 1: Diageo plc: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Diageo plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Diageo plc: M&A Average Deal Size - Value (US$m)
Figure 4: Diageo plc: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Diageo plc: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Diageo plc: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 7: Diageo plc: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 8: Diageo plc: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 9: Diageo plc: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 10: Diageo plc: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 11: Diageo plc: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Diageo plc:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Norgine B.V.:企業のM&A・事業提携・投資動向
    Norgine B.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Norgine B.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Quanta Services Inc (PWR):企業の財務・戦略的SWOT分析
    Quanta Services Inc (PWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Legend Mining Ltd:企業の戦略・SWOT・財務情報
    Legend Mining Ltd - Strategy, SWOT and Corporate Finance Report Summary Legend Mining Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Uni-President China Holdings Ltd.:戦略・SWOT・企業財務分析
    Uni-President China Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary Uni-President China Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Shanxi Zhendong Pharmaceutical Co Ltd (300158):製薬・医療:M&Aディール及び事業提携情報
    Summary Shanxi Zhendong Pharmaceutical Co Ltd (Zhendong Group) is a pharmaceutical company. The company researches, develops, manufactures and markets pharmaceutical products and Chinese medicines in China. It offers products such as cancer drugs, cardiovascular drugs, infectious disease drugs, resp …
  • Unfors RaySafe AB:医療機器:M&Aディール及び事業提携情報
    Summary Unfors RaySafe AB (Unfors), formerly Unfors Instruments AB, is a subsidiary of Fluke Biomedical, medical device company that provides solution for the X-ray room consisting of products which collect radiation. The company’s products include RaySafe ThinX, RaySafe X2, RaySafe Solo, RaySafe Xi …
  • TBEA Xinjiang Sunoasis Co Ltd:電力:M&Aディール及び事業提携情報
    Summary TBEA Xinjiang Sunoasis Co Ltd (TBEA) is a renewable energy company that manufactures and markets solar energy products. The company offers products such as photovoltaic power generation systems, monocrystalline silicon wafers, polycrystalline silicon films, inverter control system, monocryst …
  • Seplat Petroleum Development Company Plc (SEPLAT):石油・ガス:M&Aディール及び事業提携情報
    Summary Seplat Petroleum Development Company Plc (Seplat) is an independent upstream exploration and production company that offers development and operation of oil and natural gas reserves and production assets. The company produces oil from fileds such as Amukpe, Oben, Okporhuru, Ovhor, Orogho, Sa …
  • BPCE SA:企業のM&A・事業提携・投資動向
    BPCE SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BPCE SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Obsidian Energy Ltd (PWT)-石油・ガス分野:企業M&A・提携分析
    Summary Obsidian Energy Ltd (Obsidian) is formerly known as Penn West Petroleum Ltd it is a conventional oil and natural gas producer in Canada. It develops and explores oil and gas properties and related production infrastructure in the Western Canada Sedimentary Basin. Obsidian operates properties …
  • Emami Limited:戦略・SWOT・企業財務分析
    Emami Limited - Strategy, SWOT and Corporate Finance Report Summary Emami Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Fujitsu Australia Ltd:企業の戦略的SWOT分析
    Fujitsu Australia Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • iX Biopharma Ltd (42C):企業の財務・戦略的SWOT分析
    Summary iX Biopharma Ltd (iX Biopharma) is a pharmaceutical company that provides that offers drug delivery and formulation. The company's pipeline product portfolio includes development of drugs for various indications such as opioid-sparing for acute, severe and chronic pain; male erectile dysfunc …
  • Gecina SA:企業のM&A・事業提携・投資動向
    Gecina SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gecina SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • PolyNovo Biomaterials Pty Ltd:企業の製品パイプライン分析2018
    Summary PolyNovo Biomaterials Pty Ltd (PolyNovo), a subsidiary of PolyNovo Ltd is a medical technology company that develops, designs and manufactures controlled bioeroding tissue and orthopedic solutions. The company’s Novosorb polymers are based on polyurethanes, a polymer family used in medical a …
  • Unichem Laboratories Ltd (UNICHEMLAB):製薬・医療:M&Aディール及び事業提携情報
    Summary Unichem Laboratories Ltd (Unichem) is an integrated, specialty pharmaceutical company which manufactures pharmaceutical formulations, generic products and active pharmaceutical ingredients (API's). The company offers its products in the therapeutic areas of gastroenterology, anti-invectives, …
  • Fletcher Building Ltd:企業の戦略・SWOT・財務情報
    Fletcher Building Ltd - Strategy, SWOT and Corporate Finance Report Summary Fletcher Building Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Compania Espanola de Petroleos SAU:企業の戦略・SWOT・財務分析
    Compania Espanola de Petroleos SAU - Strategy, SWOT and Corporate Finance Report Summary Compania Espanola de Petroleos SAU - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Syros Pharmaceuticals Inc (SYRS):企業の財務・戦略的SWOT分析
    Summary Syros Pharmaceuticals Inc (Syros) is a biopharmaceutical company that develops medicines for the treatment of cancer, immune-mediated diseases, and other diseases. The company offers its pipeline products under clinical trials include SY-1425, an oral, potent and selective RARa agonist that …
  • Patrys Ltd (PAB):企業の財務・戦略的SWOT分析
    Summary Patrys Ltd (Patrys) is a therapeutic antibody development company focused on IgM antibodies and IgG antibody fragments in the field of oncology. The company's pipeline products include PAT-SC an immunoglobulin M type antibody used for the treatment of gastric cancer PAT-SM is a fully human m …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆